| Transcriptional control and the role of silencers in transcriptional regulation in eukaryotes S Ogbourne, TM Antalis Biochemical Journal 331 (1), 1-14, 1998 | 448 | 1998 |
| Glyphosate: environmental contamination, toxicity and potential risks to human health via food contamination SH Bai, SM Ogbourne Environmental Science and Pollution Research 23, 18988-19001, 2016 | 392 | 2016 |
| Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death SM Ogbourne, A Suhrbier, B Jones, SJ Cozzi, GM Boyle, M Morris, ... Cancer Research 64 (8), 2833-2839, 2004 | 313 | 2004 |
| Eco-toxicological effects of the avermectin family with a focus on abamectin and ivermectin SH Bai, S Ogbourne Chemosphere 154, 204-214, 2016 | 215 | 2016 |
| Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis RT Aimes, A Zijlstra, JD Hooper, SM Ogbourne, ML Sit, S Fuchs, ... Thrombosis and haemostasis 89 (03), 561-572, 2003 | 211 | 2003 |
| Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate JM Challacombe, A Suhrbier, PG Parsons, B Jones, P Hampson, ... The Journal of Immunology 177 (11), 8123-8132, 2006 | 205 | 2006 |
| PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double‐blind, vehicle‐controlled, multicentre, phase IIa study G Siller, K Gebauer, P Welburn, J Katsamas, SM Ogbourne Australasian Journal of Dermatology 50 (1), 16-22, 2009 | 182 | 2009 |
| PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial G Siller, R Rosen, M Freeman, P Welburn, J Katsamas, SM Ogbourne Australasian Journal of Dermatology 51 (2), 99-105, 2010 | 144 | 2010 |
| The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers JR Ramsay, A Suhrbier, JH Aylward, S Ogbourne, SJ Cozzi, MG Poulsen, ... British Journal of Dermatology 164 (3), 633-636, 2011 | 135 | 2011 |
| Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif GA Darnell, TM Antalis, RW Johnstone, BW Stringer, SM Ogbourne, ... Molecular and cellular biology 23 (18), 6520-6532, 2003 | 90 | 2003 |
| Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif GA Darnell, TM Antalis, RW Johnstone, BW Stringer, SM Ogbourne, ... Molecular and cellular biology 23 (18), 6520-6532, 2003 | 90 | 2003 |
| The impact of human activities on Australian wildlife A Taylor-Brown, R Booth, A Gillett, E Mealy, SM Ogbourne, ... PloS one 14 (1), e0206958, 2019 | 89 | 2019 |
| The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate SM Ogbourne, PG Parsons Fitoterapia 98, 36-44, 2014 | 84 | 2014 |
| Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches SJ Cozzi, SM Ogbourne, C James, HG Rebel, FR De Gruijl, B Ferguson, ... Journal of investigative dermatology 132 (4), 1263-1271, 2012 | 79 | 2012 |
| Induction of Senescence in Diterpene Ester–Treated Melanoma Cells via Protein Kinase C–Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway SJ Cozzi, PG Parsons, SM Ogbourne, J Pedley, GM Boyle Cancer research 66 (20), 10083-10091, 2006 | 79 | 2006 |
| Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells M Serova, A Ghoul, KA Benhadji, S Faivre, C Le Tourneau, E Cvitkovic, ... Molecular cancer therapeutics 7 (4), 915-922, 2008 | 78 | 2008 |
| Localization, expression and genomic structure of the gene encoding the human serine protease testisin JD Hooper, N Bowen, H Marshall, LM Cullen, R Sood, R Daniels, ... Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1492 (1 …, 2000 | 57 | 2000 |
| Proceedings of the first international conference on PEP005 SM Ogbourne, P Hampson, JM Lord, P Parsons, PA De Witte, A Suhrbier Anti-cancer drugs 18 (3), 357-362, 2007 | 56 | 2007 |
| Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies TTT Le, J Gardner, D Hoang-Le, CW Schmidt, KP MacDonald, E Lambley, ... Vaccine 27 (23), 3053-3062, 2009 | 52 | 2009 |
| Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells KA Benhadji, M Serova, A Ghoul, E Cvitkovic, C Le Tourneau, ... British journal of cancer 99 (11), 1808-1815, 2008 | 49 | 2008 |
